Drug Type Small molecule drug |
Synonyms JNJ 54175446, JNJ-5446 |
Target |
Action antagonists |
Mechanism P2X7 receptor antagonists(P2X purinoceptor 7 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H13ClF4N6O |
InChIKeyCWFVVQFVGMFTBD-SECBINFHSA-N |
CAS Registry1627902-21-9 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Depressive Disorder, Major | Phase 2 | United Kingdom | 12 Sep 2019 | |
| Inflammation | Phase 2 | United Kingdom | 12 Sep 2019 |





